Provista Diagnostics researchers say the company's Videssa® Breast test can help inform better decision-making after abnormal mammogram or other breast imaging results and potentially reduce the use of traditional biopsy by up to 67%. (Source: [iStock/David Marchal)

Omics and Tumor Morphology Point to Possible Breast Cancer Outcome Biomarker

Integrating multiple types of biological data for cancer samples is key to identifying potential biomarkers that can predict patient outcome. That’s the conclusion of a...
Medical: Sterile Urine sample and blood test

Urine Better than Blood for Determining Bladder Cancer Genomic Profile

Liquid biopsy using urine is better than testing blood when it comes to accurately reflecting the genomic profile of bladder cancer tumors. That’s according...

Genomind Launching Enhanced Mental Health Biomarker Test

Genomind said today it will launch an enhanced version of its mental health genetic test that will feature a new, more focused report and...
A doctor taking a patient's blood sample

Liquid Biopsy Equal to Tissue to Indicate Immunotherapy Response

Liquid biopsy is just as good as traditional tumor testing at identifying microsatellite instability (MSI), an important biomarker used to predict response to immunotherapy...

Precision for Medicine Broadens Biospecimen Offerings with ProMedDx, GLAS Acquisitions

In moves designed to strengthen its position as a provider of biomarker services for its life sciences partners, Precision for Medicine has announced the...
Lou Gehrig’s disease

Gene for Hallmark Protein Aggregates of Lou Gehrig’s Disease Uncovered

A key gene has been uncovered behind the formation of neuron-damaging protein aggregates that cause amyotrophic lateral sclerosis (ALS) and other neurological diseases. The...
Neuron system

MND Risk Split Equally Among Genetics, Environment

Scientists at Trinity College Dublin published a paper in JAMA that represented the largest ever study (“Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis”)...
Brain cancer, conceptual artwork

Single-Cell Analysis Reveals New Medulloblastoma Subtype

Researchers using single-cell analysis have gained new insight into the most common type of childhood brain cancer. The team has pinpointed where in the...

In Conversation with Clive Morris, CEO Inivata

Four-year-old liquid biopsy company Inivata, based in Cambridge, U.K., with a testing laboratory in Research Triangle Park, NC, is now making its presence felt...
3D DNA strands on a technology abstract background

Invitae Enhances Variant Interpretation Capabilities with Jungla Acquisition

Medical genetics company Invitae announced that it will acquire Jungla, Inc., a provider of genetic variant clinical interpretation tools in a deal valued at...
Scroll Up